Blue Sail Medical Co.Ltd(002382) on January 13, it was announced that Liu Wenjing, chairman of the company, will no longer serve as president in consideration of the company’s long-term strategic inheritance, incremental business development and the age echelon construction of the company’s management team. Zhong Shuqiao, former vice president and Secretary of the board, aged 36, will take over the post of president.
According to the announcement, Liu Wenjing, 50, is the chairman and President of the company. Since Liu Wenjing served as the president, the company has continuously broken through itself, transformed and upgraded, and gradually become a multinational leading medical device enterprise with a complete layout of low-value consumables and high-value consumables. In consideration of the company’s long-term strategic inheritance, incremental business development and the age echelon construction of the company’s management team, Liu Wenjing recently took the initiative to no longer serve as the president. After resigning as the president, Liu Wenjing still served as the chairman of the company and the chairman of the strategy committee, focusing on the layout of the company’s overall development strategy and exploring new space for high-quality development.
According to the announcement, Zhong Shuqiao, who took over as president this time, is 36 years old. He joined Blue Sail Medical Co.Ltd(002382) as a director, vice president, chief capital officer and Secretary of the board of directors in 2018. After Zhong Shuqiao became president of the company, he will no longer serve as vice president and chief capital officer of the company, and will continue to serve as a director and Secretary of the board of directors until the Company re appoints the Secretary of the board of directors.
The company said that Zhong Shuqiao has successively led the company’s key businesses such as major asset restructuring, overseas M & A, convertible corporate bonds and the preparation and development of new business division. He is not only familiar with the company’s development strategy, corporate culture and organizational system, but also has the courage to explore and innovate, forge ahead and start a business, and has the advantages of strategic operation, capital operation, corporate governance The professional background and practical experience of the combination of industry and capital meet the needs of the company to carry forward the past and forge ahead into the future, further improve business development and comprehensive competitiveness. In the future, the company’s management will continue to inject fresh blood, maintain entrepreneurial vitality, and continue to inherit the enterprise values of openness, inclusiveness, standardization and co creation on the basis of existing business platforms and rich resource endowments, so as to promote the company to a higher level.
The company also announced that in order to further clarify the strategic layout, improve the company’s organizational structure and management system, and clarify the positioning of the group holding company of the main body of the listed company, the company plans to carry out internal asset restructuring. Taking December 31, 2021 as the base date, part of the company’s assets and liabilities related to the production and operation of health protection gloves business are transferred to Zibo new materials and Zibo health technology, a wholly-owned subsidiary. After the internal assets reorganization, Zibo new materials and Zibo health technology will serve as the production and operation platform of the company’s health protection division, thus forming a business pattern in which the parent company Blue Sail Medical Co.Ltd(002382) serves as the holding platform and the subordinate health protection, cardio cerebrovascular and medical care divisions operate independently, making the company’s strategic layout clearer and improving the overall management efficiency, Promote the sustainable and steady development of the company.
